0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology

Buy Now

The Expanding Role of Folates and Fluoropyrimidines in Cancer Chemotherapy (Paperback, 1988 ed.) Loot Price: R1,603
Discovery Miles 16 030
The Expanding Role of Folates and Fluoropyrimidines in Cancer Chemotherapy (Paperback, 1988 ed.): Y. Rustum

The Expanding Role of Folates and Fluoropyrimidines in Cancer Chemotherapy (Paperback, 1988 ed.)

Y. Rustum

Series: Advances in Experimental Medicine and Biology, 244

 (sign in to rate)
Loot Price R1,603 Discovery Miles 16 030 | Repayment Terms: R150 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

Donate to Gift Of The Givers

Although 5-fluorouracil (Fura) is the drug of choice for the treat- ment of patients with advanced colorectal cancer, this agent has limited effectiveness with a reported response rate of 10-20% and a duration of response of only 6-9 months. The large percentage of treatment failures with this agent has spurred a continuing effort to delineate the mechanism(s) of resistance to Fura and to evaluate approaches that would selectively modulate the therapeutic efficacy of this agent. The therapeutic efficacy of FUra has been attributed to its selec- tive incorporation into RNA and to its inhibition of thymidylate syn- thase, leading to potent inhibition of DNA synthesis. Studies of cell lines in vitro and model systems in vivo have demonstrated that although mechanism sensitivity and resistanc; to Fura are multifactorial, in the presence of citrovorum factor (CF, 5-formyltetrahydrofolate) the site of action of Fura becomes predominantly the pronounced and pro- longed inhibition of thymidylate synthase. This action is the result of stabilization of the covalent ternary complex between FdUMP, an active metabolite of FUra, 5,10-methylenetetrahydrofolates, and thymidylate synthase. This effect of CF is thus an example of the concept of meta- bolic modulation.

General

Imprint: Springer-Verlag New York
Country of origin: United States
Series: Advances in Experimental Medicine and Biology, 244
Release date: April 2012
First published: 1988
Editors: Y. Rustum
Dimensions: 254 x 178 x 19mm (L x W x T)
Format: Paperback
Pages: 336
Edition: 1988 ed.
ISBN-13: 978-1-4684-5609-7
Categories: Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
LSN: 1-4684-5609-1
Barcode: 9781468456097

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

You might also like..

Kanker Schmanker!
Madelein Rust Paperback R320 R275 Discovery Miles 2 750
A Summary of: Cancer as a Metabolic…
Dr. Thomas Seyfried Paperback R477 Discovery Miles 4 770
The Biology of Cancer
Robert A. Weinberg Paperback R1,805 R1,609 Discovery Miles 16 090
Never Ever Give Up - The Inspiring Story…
Erik Rees Paperback R526 R433 Discovery Miles 4 330
Famous Old People - Being the Second…
Nathaniel Hawthorne Paperback R408 Discovery Miles 4 080
Handbook for the management of breast…
Jenny Edge, Ines Buccimazza Paperback R290 R257 Discovery Miles 2 570
How to Starve Cancer - ...and Then Kill…
Jane McLelland Paperback R631 Discovery Miles 6 310
Knowledge Beats Cancer
Albert Stegmann Alberts, Stegman Alberts, Alberts Paperback R320 R295 Discovery Miles 2 950
Kennis Klop Kanker
Albert Stegmann Alberts, Stegman Alberts, Alberts Paperback R320 R295 Discovery Miles 2 950
Coping Successfully with Prostate Cancer
Tom Smith Paperback R241 Discovery Miles 2 410
My Best Worst Year - A Breast Cancer…
Alison Tucker Paperback R280 R224 Discovery Miles 2 240
TNM Classification of Malignant Tumours…
JD Brierley Paperback R1,141 Discovery Miles 11 410

See more

Partners